Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin for Popeye Sign
NCT04750291Phase 4Unknown
- Sponsor
- AstraZeneca
- Start
- Aug 2021
- Primary completion
- Dec 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in biceps tendon rupture, sponsored by AstraZeneca. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
biceps tendon rupture
Beyond the preview
Go deeper on NCT04750291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04750291.